Tandem Diabetes Care, Inc.
TNDM
$12.09
-$0.18-1.47%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -50.52% | -29.98% | 56.86% | 39.18% | 39.19% |
| Total Depreciation and Amortization | 5.73% | 3.14% | 5.68% | 6.97% | 9.42% |
| Total Amortization of Deferred Charges | -13.42% | -17.31% | -5.22% | -5.97% | 13.49% |
| Total Other Non-Cash Items | 94.11% | 76.81% | -40.53% | -44.17% | -55.45% |
| Change in Net Operating Assets | 18.31% | -77.23% | 33.38% | 111.78% | 69.69% |
| Cash from Operations | 147.58% | 164.91% | 176.16% | 133.51% | -499.53% |
| Capital Expenditure | 18.79% | 20.92% | 28.25% | 21.56% | 39.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 233.97% | 120.22% | -140.26% | -137.42% | -139.61% |
| Cash from Investing | 171.13% | 85.67% | 72.61% | -35.04% | -7,597.97% |
| Total Debt Issued | -100.00% | -96.94% | -- | -- | -- |
| Total Debt Repaid | 83.44% | 100.00% | -- | -- | -- |
| Issuance of Common Stock | 27.97% | -64.94% | -64.94% | -73.96% | -73.96% |
| Repurchase of Common Stock | 74.67% | 63.39% | -1,539.31% | -1,539.31% | -3,894.84% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 40.13% | -35,153.52% | -35,153.52% | -6,097.78% |
| Cash from Financing | -512.91% | -154.31% | 103.43% | 14.30% | 29.28% |
| Foreign Exchange rate Adjustments | 525.60% | 81.32% | 692.45% | -223.04% | -121.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 119.76% | 92.14% | 109.12% | 30.79% | -626.16% |